Results 201 to 210 of about 2,570,952 (304)

2016 STD Prevention Conference : September 20-23, 2016, Atlanta, Georgia

open access: yes
This conference is a unique forum for professionals working in STD prevention to make connections with diverse colleagues, bridging prevention programs, science, and policy to foster multi-disciplinary conversations, solutions and partnerships.

core  

The Association Between Human Papillomavirus and Prostate Cancer: A Systematic Review and Meta‐Analysis

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Human papillomavirus (HPV), the necessary cause of cervical cancer, is associated with an increased risk of other anogenital cancers. While HPV has frequently been detected in prostate specimens, its role in prostate carcinogenesis remains controversial. We synthesized and meta‐analyzed the epidemiological literature on the association between
Sarah Botting‐Provost   +5 more
wiley   +1 more source

Sexually Transmitted Diseases: An Unprecedented Overview of Their Global Prevalence in a Study of 50,000 Participants. [PDF]

open access: yesActa Derm Venereol
Cribier B   +7 more
europepmc   +1 more source

Toward Objective Anal Cancer Screening: From Swab‐Based Genome‐Wide Methylation Marker Discovery to Novel Test Development

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Anal high‐grade squamous intraepithelial lesions (HSIL:AIN2/3) are precursors to anal cancer, and early detection and treatment through screening is crucial for effective cancer prevention. Current guidelines recommend anal swab‐based screening and highlight the need for objective biomarkers to improve risk stratification.
Kirsten Rozemeijer   +11 more
wiley   +1 more source

HPV Genotype Distribution in Cervical Cancer and High‐Grade Lesions in Norway, and Early Vaccine Impact

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy